Clinical and immunological features of rheumatoid arthritis patients with positive anti-centromere antibody: a case-control study
Abstract
Objective To characterize the clinical and immunological features of rheumatoid arthritis (RA) patients with positive anti-centromere antibody (ACA). Methods In this retrospective case-control study, the clinical manifestations, demographic data, and immunological test results of these patients were collected and analyzed. Results ACA-positive RA patients exhibited a significantly higher prevalence of Raynaud’s phenomenon (15.0% vs. 2.5%, χ2 = 4.838, P = 0.028), xerostomia (22.5% vs. 8.8%, χ2 = 4.363, P = 0.037), xerophthalmia (27.5% vs. 10.0%, χ2 = 6.128, P = 0.013), and interstitial pneumonia (27.5% vs. 5.0%, χ2 = 12.343, P < 0.001), as well as higher rates of elevated ALP (18.9% vs. 1.3%, χ2 = 9.780, P = 0.002) and GGT (33.33% vs. 15.0%, χ2 = 5.086, P = 0.024). Conclusion ACA-positive RA may present a unique phenotype characterized by an increased risk of interstitial lung disease, sicca symptoms, and cholestatic liver injury; thus, enhanced pulmonary/hepatic screening and tailored monitoring strategies are critical.
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.